Skip to Content

Revasc

Active Substance: desirudin
Common Name: desirudin
ATC Code: B01AE01
Marketing Authorisation Holder: Canyon Pharmaceuticals Ltd.
Active Substance: desirudin
Status: Withdrawn
Authorisation Date: 1997-07-09
Therapeutic Area: Venous Thrombosis
Pharmacotherapeutic Group: Antithrombotic agents

Therapeutic Indication

Prevention of deep venous thrombosis in patients undergoing elective hip or knee replacement surgery.

The marketing authorisation for Revasc has been withdrawn at the request of the marketing-authorisation holder.

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide